AOL’s StyleList Speaks With Spencer Kobren About Women’s Hair Loss

Hair Loss in women is a silent epidemic of tremendous proportions. More than forty percent of hair loss sufferers in the U.S are women and a large percentage of these women are between the ages of 18 to 35.

As disturbing as male pattern baldness is for men, for women, hair loss can be downright devastating.

This week AOL’s StyleList takes a closer look at this growing epidemic.

Read the story:  Women’s Hair Loss: Top Reasons Your Hair is Falling Out

For complete online support check out the AHLA recommended Women’s Hair Loss Project and WHLP message forums.

AMERICAN HAIR GROWTH CENTERS’ STEVE BENNIS ACCUSED OF FRAUD

FOX Chicago News has been investigating  alleged con artist Steve Bennis to find out how he’s managed to stay in business in Chicago for at least five years, despite repeated lawsuits claiming he’s been committing fraud.

View FOX News report:

Celebrity Hair Transplant – What’s The Deal With Matthew McConaughey’s Hair?

Twenty – four year old hair wearer James calls the program to give us an update and to reiterate how adding a small frontal hair piece has changed his life. He also had some very interesting celebrity hair loss news to share.

Listen to the segment:

The Sobering Reality of Living With Hair Loss

Listen as Spencer Kobren and  the crew discuss the social and interpersonal issues that hair loss sufferers are faced with and how to get passed the sometimes crippling effects of feeling uncomfortable in our own skin.

Philadelphia Radio Personality Reaches Out For Hair Loss Help

Last night one of Philadelphia’s morning drive DJs called to speak to the guys and to discuss his recent struggles with hair loss.

Listen to the segment:

Propecia Side Effects - Fact Or Fiction

Fear mongering anti-Propecia videos and websites are popping up all over the internet making the decision to effectively treat hair loss even more confusing. Should consumers be legitimately concerned by claims of permanent long term adverse side effects from the drug, or are these videos and websites simply agenda driven anti-Propecia propaganda?

IAHRS accepted member William H. Reed, M.D. discusses his findings of an informal study in which he polled 17 hair restoration practices that have treated more than 30,0000 patients with the drug.

The bottom line: Out of more than 30,000 patients who were prescribed Propecia, not a single one has ever complained of long-term irreversible side effects of any kind.

Listen to the interview:

Follica, Inc. - It’s Not Personal, It’s Business

You would think that the online hair loss community would be thrilled to get the news that the baldness inspired biotech startup, Follica Inc., raised another $7.5 million in equity financing. You would also think that with a total of $13 million raised by the company in its series B round of funding, that the public would understand that something good is happening here.

Well think again. While it’s no secret that emotions run high for many active readers and posters in our community, some of the more emotional and vocal members are sharply criticizing Follica Inc. and its partners for attempting to keep their business plan and progress close to their collective vest.

No matter how desperate we are as hair loss sufferers, it’s important to understand that any organization that is legitimately involved in the race to effectively treat or cure hair loss has an obligation to its investors to maintain a certain level of knowledge management. [Read more]

Histogen’s HSC Complex - An In Depth Discussion

The hair loss world is buzzing about Histogen’s small, but impressive pilot clinical trial. Despite some much talked about setbacks, it looks like it’s “all systems go” for the San Diego based startup.

Last year Histogen was forced to layoff thirty six of it’s employees after its fundraising efforts were stifled when a rival company located in Carlsbad, CA called SkinMedica, filed a patent infringement lawsuit against the the company. While the case is still pending, Histogen’s founder and CEO, Dr. Gail Naughten was still able to raise enough cash to keep her core group of researchers and employees on the job. Naughton states that Histogen has also received the substantial funding needed to underwrite the additional studies that are soon to take place in Singapore.

The hair loss community has its collective fingers crossed, as is illustrated by the tone of last weeks Tuesday night TBT broadcast.

Here’s a segment:

APCDD1- Researchers Identify Hair Loss Gene

Scientists from from Colombia, Rockefeller and Stanford Universities, believe they have discovered a gene that significantly  impacts hair growth as well as hair follicle miniaturization; the phenomenon that is the cornerstone of male and female pattern baldness.

The gene identified is named APCDD1 (adenomatosis polyposis down-regulated 1), and was found in patients suffering with hereditary hypotrichosis simplex, a condition that usually presents itself in childhood. Hereditary hypotrichosis simplex is a rare autosomal dominant form of hair loss characterized by hair miniaturization, a process in which the hair follicle actually shrinks and normal thick terminal hair is gradually replaced with fine, velus hair.
[Read more]

Histogen’s HSC Shows Continued Hair Growth At One Year - Listen to Exclusive TBT Interview

Exclusive interview with Histogen Inc. CEO and Founder Dr. Gail Naughton:

HSC Trial Shows Continued Significant Hair Growth at One Year Follow-up

Histogen to present one year clinical trial data at Society for Investigative Dermatology Annual Meeting

SAN DIEGO, April 13, 2010 – Histogen, Inc., a regenerative medicine company developing solutions based on the products of newborn cells grown under embryonic conditions, today announced the one year data findings of its Hair Stimulating Complex (HSC) pilot clinical trial. Statistically significant new hair growth was seen in HSC-treated subjects at this follow-up timepoint, one year after their single treatment with HSC. [Read more]

Next Page »